Company · CIK 0001601485 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Elicio Therapeutics, Inc. · ELTX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 AForm 4 → | Sep 2, 4:05 pm EDT | Julian AdamsDirector | 21,750 | — | — | 21,750 | — | |
| Aug 31, 2026 AForm 4 → | Sep 2, 4:04 pm EDT | Carol Gail AsheDirector | 21,750 | — | — | 21,750 | — | |
| Aug 31, 2026 AForm 4 → | Sep 2, 4:04 pm EDT | Yekaterina ChudnovskyDirector, 10% Owner | 21,750 | — | — | 21,750 | — | |
| Aug 31, 2026 AForm 4 → | Sep 2, 4:03 pm EDT | Allen NissensonDirector | 21,750 | — | — | 21,750 | — | |
| Aug 31, 2026 AForm 4 → | Sep 2, 4:03 pm EDT | Robert R RuffoloDirector | 21,750 | — | — | 21,750 | — | |
| Aug 31, 2026 AForm 4 → | Sep 2, 4:03 pm EDT | Karen J WilsonDirector | 21,750 | — | — | 21,750 | — | |
| Aug 31, 2026 AForm 4 → | Sep 2, 4:02 pm EDT | Jay VenkatesanDirector | 21,750 | — | — | 21,750 | — | |
| Jul 16, 2026 AForm 4 → | Jul 17, 4:14 pm EDT | Christopher HaqqSee Remarks | 64,643 | — | — | 64,643 | — | |
| Jul 16, 2026 AForm 4 → | Jul 17, 4:14 pm EDT | Peter DeMuthChief Scientific Officer | 52,832 | — | — | 52,832 | — | |
| Jul 16, 2026 AForm 4 → | Jul 17, 4:13 pm EDT | Preetam ShahSee Remarks | 60,833 | — | — | 60,833 | — | |
| Jul 16, 2026 AForm 4 → | Jul 17, 4:13 pm EDT | Robert ConnellyCEO, President and Director, Director | 186,944 | — | — | 186,944 | — |